ALX ONCOLOGY HOLDINGS INC Annual Interest Expense in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Alx Oncology Holdings Inc quarterly/annual Interest Expense history and growth rate from 2021 to 2024.
  • Alx Oncology Holdings Inc Interest Expense for the quarter ending December 31, 2024 was $427K, a 2.89% increase year-over-year.
  • Alx Oncology Holdings Inc Interest Expense for the twelve months ending December 31, 2024 was $1.73M, a 10.5% increase year-over-year.
  • Alx Oncology Holdings Inc annual Interest Expense for 2024 was $1.73M, a 10.5% increase from 2023.
  • Alx Oncology Holdings Inc annual Interest Expense for 2023 was $1.57M, a 558% increase from 2022.
  • Alx Oncology Holdings Inc annual Interest Expense for 2022 was $238K, a 1731% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.73M +$164K +10.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $1.57M +$1.33M +558% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $238K +$225K +1731% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-06
2021 $13K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.